Inoviq Ltd has released a press release.
NEURO-NET validated in Parkinson's
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Inoviq
- Quarterly Activities Report and Appendix 4C - June 2024
- Successful completion of Share Purchase Plan
- INOVIQ lodges SPP and Options Prospectus
- INOVIQ isolates brain-derived exosomes in Alzheimer's
- INOVIQ completes $7m placement
Later from Inoviq
- Quarterly Business Update and Appendix 4C - September 2024
- INOVIQ receives $1m RDTI refund
- AGM CEO Presentation
- EXO-OC test delivers outstanding performance
- Disease Specificity study completed for NeuCA15-3 test
Follow Inoviq into a list and get an email when it puts out news.
Follow Inoviq